Indigenous Trauma- and Equity-Informed Practice

To honour September 30th, National Day for Truth And Reconciliation, and to respond to Call to Action 24 in the  Truth and Reconciliation Commission of Canada: Calls to Action Report, Continuing Professional Development for Pharmacy Professionals (CPDPP) in collaboration with Saskatchewan College of Pharmacy Professionals, Alberta College of Pharmacy and College of Pharmacists of Manitoba presents an informative and meaningful learning experience with Len Pierre Consulting.

Len Pierre Consulting is a multidisciplinary team of consultants and facilitators who advise and train teams on Indigenous Cultural Safety, Reconciliation, Decolonization & Anti-Racism. The team’s philosophy is to provide education that inspires the heart, mind and spirit of professionals and supports professionals to lead towards systemic change, while embedding practical strategies for culturally safe and equitable professional practice. Please click here for full bio.


Recording: This event has already happened. To view the recording, click on the button below and register. 

Date: Friday, September 30th, 2022 9:00 am - 10:30 am (AB/SK) 1.5 hours

Target Audience: All pharmacy professionals and staff who support the practice of pharmacy

CPDPP Accreditation: 1.5 CEUs

Registration Fee: Free

At the end of this presentation, participants will be able to:

  1. Define concepts of cultural safety for health care professionals.
  2. Describe how to create culturally safe spaces in the workplace.
  3. Identify how to embed and reflect Indigenous resilience in policy and projects.
  4. Create equity-orientated strategies in professional practice.
  5. Facilitate and advocate for Indigenous trauma-informed practice.

NAPRA Model Standards for Sterile Compounding

Brittany Sharkey, Certified Compounding Inspector and Saskatchewan College of Pharmacy Professionals (SCPP) Field Officer, will be reviewing the NAPRA Model Standards for Sterile Compounding.

This presentation is only available as a recording. 


Target Audience: Pharmacists and Pharmacy Technicians

Presenter: Brittany Sharkey

Accreditation: This event will be accredited for 1.5 CEUs

After this presentation participants will be able to:

  1. Describe the requirements of NAPRA’s Non-Hazardous Sterile Standards.
  2. Identify personnel expectations for sterile compounding, including staff training and assessment
  3. Understand anteroom and clean room requirements for sterile compounding.
  4. Outline the quality assurance program requirements for sterile compounding.
  5. Summarize specific requirements for hazardous sterile compounding.

Prescribing Paxlovid™ (nirmatrelvir and ritonavir) for COVID-19

You are invited to attend a training session for Saskatchewan community prescribers to familiarize themselves with the prescribing requirements for publicly-funded Paxlovid™ treatment for early Covid-19.  You must register for one of these sessions to receive a recording.

This recording is distributed by CPDPP. Please email cpdpp@usask.ca to request the recording.

Target Audience: While these sessions are meant to support community prescribers for Paxlovid™ for COVID-19, all Saskatchewan health care providers are invited to attend.

Accredited by CPDPP: for 1.5 CEUs

Speakers: Kirsten Bazylak, BSP, medSask/CPDPP
                  Dr. S. Takaya, MD, FRCPC, Infectious Disease
                  Dr. S. Lee, MD, FRCPC, Internal Medicine and Infectious Disease

At the end of the training, participants will be able to:

  1. Understand patient assessment and prescribing process requirements for community prescribing of Paxlovid™ for mild COVID-19.
  2. Identify patients requiring referral and describe the referral process to ensure timely access to care.
  3. Outline Saskatchewan guidance on drug interactions and how to manage at a community prescriber level.
  4. Locate helpful resources and additional supports for Paxlovid™.
  5. Share experiences and insights from experts working in infectious disease and treatment of early COVID-19.

Saskatchewan Cancer Agency (SCA) Medications and the Pharmaceutical Information Program (PIP)

Medications dispensed by the Saskatchewan Cancer Agency (SCA) will now be captured in the PIP/eHealth Viewer and be on display by all who access PIP/ eHealth Viewer. This webinar covers details of what pharmacy staff can expect to see with this change and their professional responsibilities when viewing medications used to treat cancer. The webinar will be available live and registrants will be provided with a recording after the event.


Target Audience: All Saskatchewan pharmacy staff

Presenter: Alex Martinson, BSP, ACPR, Provincial Manager Oncology Drugs Programs, Access and Analytics, Saskatchewan Cancer Agency

Please register to watch the this recording on demand. Register here. 

CPDPP Accreditation: 1.5 CEUs

Registration Fee: Free

This presentation will allow participants to:

  1. Describe SCA pharmacy professional roles when a patient is prescribed a cancer treatment medication.
  2. Explain the “5 Ws” (why, who, where, when and what) of SCA medications that will be captured on PIP/ eHealth Viewer.
  3. Outline the specific information regarding cancer treatment medications that will be available on PIP/eHealth Viewer.
  4. Summarize how to incorporate cancer treatment medications now viewed on PIP/eHealth Viewer into practice and how to support patients undergoing cancer treatments.
  5. Identify quality oncology resources and how to access them.

Supporting People Taking Methadone

This session facilitated by medSask and CPDPP will provide information and resources for all health care providers about the upcoming changes from compounded methadone to commercially available products and how to support people taking methadone during the transition.

This recorded webinar includes a presentation followed by a question period.


Target Audience: Healthcare professionals in Saskatchewan who support people taking methadone

Presenters:

  • Amy Wiebe (Continuing Professional Development for Pharmacy Professionals)
  • Kris Berg (Pharmacy Association of Saskatchewan)
  • Janis Johnson (Saskatchewan Drug Plan and Extended Benefits Branch)
  • Dr. Morris Markentin (OATP Medical Manager, College of Physicians and Surgeons of Saskatchewan)

Registration: To view the recording of the webinar and Q&A section, follow the registration link below. 

  1. Summarize reasons for the change in available methadone products in Saskatchewan.
  2. Describe the different commercially available methadone products available in Saskatchewan and support product selection.
  3. Demonstrate strategies and workflow processes to enhance patient safety through the transition period.
  4. Explain updates to pharmacy billing for commercially available methadone products.